Syndax Pharmaceuticals Breach Exposes SSNs and More

January 2024 Data Breach

On January 29, 2024, Syndax Pharmaceuticals experienced a security breach when an unauthorized third party accessed their internal systems. This breach was discovered on the same day it occurred, and it was found that the intruder may have accessed files containing sensitive personal information of individuals associated with the company.

Information Exposed

The types of consumer information exposed during this breach include:

• Name
• Address
• Social Security Number

Syndax Pharmaceuticals's Response

Immediately after detecting the breach, Syndax Pharmaceuticals launched a formal investigation with the help of external cybersecurity experts. The company was able to contain the threat by the following day, January 30, 2024. Since then, they have been working diligently to bolster their security measures to prevent future incidents. Syndax Pharmaceuticals has also provided affected individuals with complimentary access to Experian IdentityWorksSM for 24 months, a service that helps monitor and protect personal information.

Steps to Take if You Are Affected

If you believe your information was compromised in this breach, it is crucial to act promptly to protect your identity. Here are some steps you can take:

1. Enroll in the offered Experian IdentityWorks service by visiting the Experian IdentityWorks website and using the provided activation code before May 31, 2024.
2. Monitor your financial accounts for any unauthorized activity and report them immediately.
3. Consider placing a fraud alert or a credit freeze on your credit reports.
4. Obtain a police report if you believe there has been fraudulent use of your information.
5. Use the Identity Restoration services provided by Experian if necessary, which include assistance with disputing charges and closing accounts, among other benefits.

About Syndax Pharmaceuticals

Syndax Pharmaceuticals is a biotechnology firm based in Waltham, Massachusetts. They focus on the development of cancer therapies and are committed to delivering new options for cancer patients. For more information, you can visit their website at Syndax Pharmaceuticals.

For further details on the breach and how to protect your information, please refer to the official notice provided by Syndax Pharmaceuticals.